-$0.11 EPS Expected for Transenterix Inc (NYSE:TRXC) This Quarter
Equities research analysts expect Transenterix Inc (NYSE:TRXC) to announce earnings of ($0.11) per share for the current quarter, according to Zacks. Two analysts have provided estimates for Transenterix’s earnings. The lowest EPS estimate is ($0.11) and the highest is ($0.10). Transenterix also reported earnings of ($0.11) per share during the same quarter last year. The business is expected to issue its next quarterly earnings results on Friday, August 4th.
On average, analysts expect that Transenterix will report full-year earnings of ($0.42) per share for the current year, with EPS estimates ranging from ($0.45) to ($0.37). For the next year, analysts expect that the company will post earnings of ($0.33) per share, with EPS estimates ranging from ($0.42) to ($0.29). Zacks’ EPS calculations are a mean average based on a survey of sell-side research analysts that follow Transenterix.
Separately, B. Riley reissued a “buy” rating and set a $2.75 price objective on shares of Transenterix in a report on Sunday, March 12th.
Transenterix (NYSE TRXC) opened at 0.6893 on Monday. The company’s market capitalization is $102.38 million. Transenterix has a 52 week low of $0.45 and a 52 week high of $2.33. The stock’s 50 day moving average price is $0.56 and its 200 day moving average price is $1.07.
ILLEGAL ACTIVITY WARNING: “-$0.11 EPS Expected for Transenterix Inc (NYSE:TRXC) This Quarter” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/08/04/0-11-eps-expected-for-transenterix-inc-nysetrxc-this-quarter-updated-updated-updated.html.
Transenterix Company Profile
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related stocks with our FREE daily email newsletter.